Related Experiment Video
Updated: Jul 9, 2026

A Novel Method for the Culture and Polarized Stimulation of Human Intestinal Mucosa Explants
Published on: May 1, 2013
Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor
Background & Aims:
Mucins form an integral part of innate host defenses against intestinal pathogens and irritants. However, the mechanisms whereby mucin secretion is regulated during inflammation are poorly understood. Because prostaglandin E(2) (PGE(2)) is prominent during intestinal inflammation, we investigated its receptor-signaling pathway coupled to mucin exocytosis in the colonic epithelial cell line LS174T and rat colon.
Methods:
Reverse-transcription polymerase chain reaction (RT-PCR) and [(3)H]PGE(2) binding assays were used to identify the PGE(2) receptors (EP). Intracellular cyclic adenosine monophosphate ([cAMP](i)) was quantified by enzyme immunoassay. Mucins were metabolically labeled with [(3)H]glucosamine, and mucin secretion was quantified by Sepharose 4B column chromatography, immunoblot analysis, and cesium chloride density gradient centrifugation.
Results:
RT-PCR and DNA sequence analysis identified EP(2), EP(3), and EP(4) receptors. Mucin secretion and [cAMP](i) production by LS174T cells were stimulated dose-dependently by PGE(2), the EP(4)-receptor agonist 1-OH-PGE(1), and the EP(3)/EP(4) agonist M&B28767 and were inhibited with the adenylate cyclase inhibitor SQ22536. The EP(1), EP(2), and EP(3)/EP(1)-receptor agonists iloprost, butaprost, and sulprostone, respectively, had no effect. Similar results were obtained in rat colonic loop studies confirming that the EP(4) receptor is linked to mucin exocytosis in vivo. [(3)H]PGE(2) binding to cell membranes identified a high-affinity binding site that was competitively inhibited by M&B28767 (EP(3)/EP(4)) > 1-OH-PGE(1) (EP(4)) > sulprostone (EP(3)/EP(1)) > butaprost (EP(2)).
Conclusions:
PGE(2) coupling to the EP(4) receptor stimulates [cAMP](i)-dependent mucin exocytosis.
Insights
Prostaglandin E(2) (PGE(2)) stimulates mucin secretion via the EP(4) receptor, increasing cyclic adenosine monophosphate (cAMP) levels. This pathway is crucial for innate host defense in the colon.
Area of Science:
- Gastroenterology
- Immunology
- Cell Biology
Background:
- Mucins are key components of the innate immune system in the intestines, protecting against pathogens and irritants.
- The regulation of mucin secretion during inflammation is not well understood.
- Prostaglandin E(2) (PGE(2)) is a significant mediator during intestinal inflammation.
Purpose of the Study:
- To investigate the receptor-signaling pathway of prostaglandin E(2) (PGE(2)) in regulating mucin exocytosis.
- To determine the role of specific prostaglandin E(2) receptors (EP) in colonic mucin secretion.
- To elucidate the downstream signaling mechanisms, including cyclic adenosine monophosphate (cAMP), involved in PGE(2)-mediated mucin release.
Main Methods:
- Identification of EP receptors using reverse-transcription polymerase chain reaction (RT-PCR) and [(3)H]PGE(2) binding assays.
- Quantification of intracellular cyclic adenosine monophosphate ([cAMP](i)) via enzyme immunoassay.
- Measurement of mucin secretion using metabolic labeling, column chromatography, immunoblot analysis, and density gradient centrifugation.
Main Results:
- EP(2), EP(3), and EP(4) receptors were identified in colonic epithelial cells.
- PGE(2) and specific EP receptor agonists (EP(4) and EP(3)/EP(4)) dose-dependently stimulated mucin secretion and [cAMP](i) production.
- Inhibition of adenylate cyclase blocked the stimulatory effects, confirming the involvement of the cAMP pathway.
- EP(4) receptor activation was confirmed to be linked to mucin exocytosis in vivo using rat colon models.
Conclusions:
- Prostaglandin E(2) (PGE(2)) stimulates mucin exocytosis through coupling to the EP(4) receptor.
- This process is dependent on the elevation of intracellular cyclic adenosine monophosphate (cAMP) levels.
- The EP(4) receptor-cAMP pathway represents a significant mechanism for regulating mucin secretion in the colon.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs for Treatment of Constipation-Predominant IBS
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Inflammatory Bowel Disease II: Ulcerative Colitis

